Highmark will no longer accept price markups on some oncology-related services beginning April 1, the Pittsburgh insurer announced Wednesday, a move that health provider giant UPMC promptly labeled "an egregious contract violation." What's at stake is some $200 million in annual markups for cancer treatments from a variety of providers -- including UPMC -- double the amount billed from just three years ago, said pediatric cardiologist Donald R. Fischer, chief medical officer for Highmark Blue Cross Blue Shield. "It was growing uncontrollably," he said, "so we decided to fix this."
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
